ALS
Center Web Site
Research
People and Events |
| In
This Issue:
Drug
Trinity Shows Unexpected Strength
Jean-Pierre Julien—his “cocktail”
does wonders for ALS mice.
From
Iceland: A New Way to Decode ALS Genes
In Iceland, a country of roughly 300,000 citizens,
ALS is pretty much unknown. If you wanted to find genes tied to
that disease, it’s an unlikely spot for a search. But from
that country may come, if not the genes themselves, a superior way
to track them down.
Getting
to the
Heart of It
With ALS, many of the simplest questions remain
unanswered. ‘That just won’t do,’ say Center scientists.
One
Step Closer to the Bedside
The Basics Bolster Stem Cell Therapy.
Available Issues:
Winter
2001/2002
Fall
2002
Spring
2003
Fall
2003
Spring
2004
Fall
2004
Winter
2005
Spring/Summer
2005
Fall 2005
Winter 2006
About
ALS Alert |
|
Runners, Walkers Make Feet Fly
to Help the Center
|
Angell’s winning form will help the Center to the
cure.
|
I ran the New York City Marathon in 1998 as
part of a charity team,” says Margaret Angell, now 26, “and
it was fantastic.” A few months earlier, Angell’s
mother had been diagnosed with ALS, and the two events had to
have set the young woman’s mind in motion. By 2001, she’d
cajoled friends—her “ALS Marathon Team”—into
running in four separate races. Angell, who comes from a family
well-versed in philanthropy, donated the team’s $500,000
in donations to research. But organizing the team, her job and
heavy volunteer work took a toll. “I was close to burnout.”
This year, though, Angell got out the team once more. Lucky for
us. The racers netted $150,000 and, this time, split the money
between the Center and The ALS-Therapy Development Foundation
in Boston. The gift has sparked a collaboration between the two
groups, aimed at getting a test drug through preclinical stages
in record time.
Meanwhile, on the West Coast, Karen Sammis and three friends
are also running for those who can’t. Like Angell, Sammis
is an athlete whose mother has ALS. Last year her group organized
the first TriOne triathlon in Alameda, Calif.—no small accomplishment
for women with full-time jobs—drawing 500 of the fittest
and contributing $6,500 to the Center. “We think we’ll
get 1,200 athletes this year,” says Sammis of the August
24 event.
At a gentler pace, determined walkers in North Oaks, Minn., also
pounded pavement to raise money for The Packard Center. Their
"Walk4Life," an event sponsored by the Playing 2 Win
4 Life Foundation for ALS Research, collected $50,000 for gene
therapy and drug development studies. Playing 2 Win is the Chicago-based
creation of Bob Basten, a corporate accounting maverick and new
member of the Center’s board of governors.
|
Collaboration is in the air. This January, the Center announced
its first funding partnership with The ALS Association.
ALSA is helping support research of Center scientist Philip
Wong, who’s working on a model of juvenile ALS. David
Borchelt will also get help for his work linking specific
SOD1 mutations with the disease process.
|
Next > Insider's
View
Noah Lechtzin, M.D., is a Hopkins pulmonologist who sees ALS clinic
patients regularly.
|
 |
Special Features:
Vantage
Point
With approaches to ALS therapy, progress seems to move one step
forward and a half step back.
On
Center
Runners, Walkers Make Feet Fly to Help the Center.
Rich
Soil for a Blooming Friendship
“About six years ago, I ran into Laura and I could tell something
wasn’t right,” says Coleman, who now directs the New
York State Trial Lawyers Association. “When I heard later
she had ALS, I felt a bit strange in writing a personal letter out
of the blue, but I sent it anyway.”
Insider's
View
Noah Lechtzin, M.D., is a Hopkins pulmonologist who sees ALS clinic
patients regularly.
From
the Clinic
Lora Clawson, M.S.N., C.R.N.P., manages Johns Hopkins’ ALS
clinic, including its clinical trials. In this column she answers
typical patients’ questions.
A
Friend Indeed
Ride for Life Keeps Center Rolling.

|
 |